Nanosphere Health Sciences Inc (PK) (NSHSF) Cotización

NSHSD Receives Major European Patent, 2days before announced Reverse Split Date: https://worldwide.espacenet.com/patent/search/family/052828626/publication/EP3057604B1?q=EP3057604B1&fbclid=IwAR2xGSWqfAW0mYA2pDxLedCj9r3ZYGGILDsaR4Coqlrd9EtySp_OahJoCB4

NSHSF: effective July 7,2021 a one for 20 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

Wow! That stinks! Just watched Curiosity Stream, and these guys seemed to be innovative. Unfortunately they can't get their financial house in order.

News - NanoSphere Health Sciences Inc. News Release

Link: http://www.globenewswire.com/news-release/2019/11/30/1954251/0/en/NanoSphere-Health-Sciences-Inc-News-Release.html

November 29, 2019 21:00 ET | Source: Nanosphere Health Sciences
Vancouver, BC, Nov. 29, 2019 (GLOBE NEWSWIRE) -- NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) (“Nanosphere” or “the Company”) reports that it has re-priced and extended the expiry date of an aggregate of 6,190,235 warrants. The warrants were originally issued pursuant to a private placement on December 4, 2017, had an exercise price of $0.75 and had an expiry date of December 4, 2019. The warrants, as amended, will have an exercise price of $0.55 and will expire on December 4, 2021.

The Company further advises that a liquidating trust acting on behalf of the creditors of a company that declared bankruptcy in 2006 has initiated a lawsuit against a former director-officer of the Company in the Federal District Court of Colorado. The claim alleges that the former director-officer made fraudulent disclosures of his financial resources to the trust in connection with the settlement of prior litigation relating to the bankruptcy, resulting in the trust being defrauded into executing the settlement and releasing the former director-officer from the litigation. The trust has named the Company and NanoSphere Health Sciences, LLC (“Nano LLC”), as well as a number of other individuals and business entities, as third party defendants in the current action based on the trust’s assertion that Nano LLC, established in 2013, was founded on funds received from the former director-officer and thus conspired in the fraud. The trust has made no attempt to quantify the claim or amount of damages it is asserting versus the Company. The Company vigorously denies any wrongdoing or liability to the trust and considers the claim against the Company to be frivolous. Based on advice received from litigation counsel, the Company considers the prospect for judgement against the Company to be remote as the claim appears to lack merit, and the Company will vigorously defend itself and seek dismissal from the action. The trustee and the former director-officer are currently in settlement discussions.

The Company further advises that its licensee for Evolve products in Colorado has indicated that it is unable to maintain its manufacture and distribution of the Company’s Evolve products within that territory. The parties are in discussions with respect to the dissolution of the license arrangement and the Company intends to seek out a new licensee.

On behalf of the Board
Mark Percival, President and CEO
E-mail: mpercival@nanospherehealth.com

Investor Contact:
Victor Goncalves, Executive Vice President
Mobile: 204-997-5517
E-mail: vgoncalves@nanospherehealth.com



About NanoSphere

NanoSphere Health Sciences is a nanobiotechnology firm specializing in proprietary delivery systems for therapeutic agents. Our patented technology transforms our strategic partner’s good products into great products, further differentiating them in their respective markets.

For more information on NanoSphere, please visit: www.NanoSphereHealth.com.



About Evolve Formulas

Evolve branded products are produced under license by leading manufacturers utilizing NanoSphere Health Science’s proprietary, patented NanoSphere Delivery System TM.

For more information on Evolve Formulas, please visit: www.EvolveFormulas.com.



The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Forward Looking Statement Caution

This news release includes forward looking statements that are subject to assumptions, risks and uncertainties. Statements in this news release which are not purely historical are forward looking statements, including without limitation any statements concerning the Company's intentions, plans, estimates, expectations or beliefs regarding the future. Although the Company believes that any forward looking statements in this news release are reasonable, there can be no assurance that any such forward looking statements will prove to be accurate. The Company cautions readers that all forward looking statements, including without limitation those relating to the Company's future operations and business prospects, are based on assumptions none of which can be assured, and are subject to certain risks and uncertainties that could cause actual events or results to differ materially from those indicated in the forward looking statements. Without limitation, these include assumptions, risks and uncertainties inherent in completing sub-licensing arrangements in the United States, Canada and abroad, product demand, production, competition and government regulation of the Cannabis industry, any and all of which may have an adverse effect on the Company’s expansion plans, sales, revenues and its financial results and condition. Readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance on forward looking statements. Any forward looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward looking statements, or to update the reasons why actual events or results could or do differ from those projected in the forward looking statements, whether as a result of new information, future events or otherwise.

Kate Wells
NanoSphere Health Sciences
(303) 324-7358
kwells@nanospherehealth.com

Sitting on a $100,000 units, happily awaiting for the Canadian Market to kick in. Then the world will once again watch how etc. Nanosphere will then be anticipated throughout the rest of the world.

Not sure bore ACB steps up to participate or be left behind a curve.

Lots to come yet, so far not much but be patent. I went in not expecting anything than a long.

Halted

No need for (disrupt) smoking, vapes, edibles, etc. ?
https://investorshub.advfn.com/Nanosphere-Health-Sciences-Inc-NSHSF-33077/




Feb 7th :




One month later :

$NSHS under pressure again today

has anyone tried the evolve products...?

The States just keep on coming. Hello Oregon!

$NSHS has steady new flow which is great https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aNSHS-2720028&symbol=NSHS®ion=C

Putting $NSHS on the watch list

This one is set explode $$$$$
Am in NSHSF $$$$

and congratulations on another %25 today buddy.

I really wanted to get some more yesterday towards close but my bid never got filled. Hopefully she settles back down for a bit today and I can pick up some aground .33-.35

lol I'm just trying to bring awareness to the company. So many people are putting money into a company with no sales, no patents, no anything. It's lunacy. This company already has licencing agreements in place with a number of places as I am sure you are aware. The price has doubled in the last week or so due to news. Wait til they sign more agreements with the rest of the states.

Ok so your account was created a week ago. Your first and only 2 posts are about NSHSF. Either paid pumper or working for company. LOL. Jk! I am long here too. What’s your story?

APYP NSHS

APYP is going up.

Check out NSHS for a CBD play with real sales. Just sold 60000 units to Mexico. Have a patented CBD delivery system that is like a nicotine patch. Its going to be big

60,000 units just sold to Mexico, Big Patent!! Juicy hold

Not much of a following on this board but I am interested in cannabis products. Lets see the market open up for oral medications like Nanosphere's.

NEWS! https://www.ftmig.com/cannabis/delta-9-signs-master-license-agreement-with-nanosphere-health-sciences/

We are LIVE NOW on MidasLetter with David Sutton, President & CEO of NanoSphere Health Sciences, LLC! #NSHS

Watch live: ?https://www.facebook.com/Followthemoneyinvestorgroup/videos/509189042928527/?

Don't think there is any earth shattering news in the article for anyone already familiar with the company. But a little exposure in Forbes can't hurt.

Article in Forbes. https://www.forbes.com/sites/irisdorbian/2018/08/24/a-septuagenarian-serial-entrepreneur-ditches-the-quiet-life-for-cannabis/#402ad5446323

Not sure exactly what you mean... but it does still trade on the grey market.

https://www.otcmarkets.com/stock/NSHSF/overview

Hopefully they uplist before summers end, but at this point its looking more like 2019

I’m looking at the trades and it’s all grey, what does that indicate?

Nice news today!

Welcome to the board! Glad to see another investor. I think as soon as they uplist to the OTC Nanosphere will be recognized. I like them as deep sleepers along with EHVVF and ZLDAF.

Best hidden gem around this price range.

Agreed. I am going to double my position down here as well.

I like the float and insider ownership as well.

I've bought small chunks down in the .30 range because the value is there in the patent alone imo. Evolve will hopefully become a go to brand for dispensaries and doctors one day, but even if that doesn't happen they will license the tech out. It will be very exciting to see them grow. We are EARLY here. Slow and steady wins the race.

I thought that dip might be the start of something a little bigger. But now with the volume that entered on Friday I am beginning to think that was a bottom. MJ market has been rather bland for quite a while and I thought perhaps the big boys might drive it down one more time before they began to load up for this summer and beyond. Still will be a bargain anywhere in this price range. Just chafes my cheapskate.

No I didn't. I am envious. I was trying to get it slightly cheaper. I don't have much of an account so I try to make every dollar buy as much as possible. Will be watching it closely Monday and jump in quick if it looks like it is going to take off. I do think this could be a big one.

You buy on that dip? I got an extra 5000 shares in at .32 :)

I agree totally. I was just curious in the Evolve product as an example of that delivery system.

I do not :/ Their own Evolve product line is really only 1/5th of the reason I am invested. It's great that they are in a 100 dispensaries, but if they lisence the tech they can be in 100 products in a single dispensary, or pharmacy. This patent could truly revolutionize medical delivery applications for any fat soluble medicine.

Would you happen to know anyone personally that has tried their EVOLVE product? If so what was their experience?

Agree, this is a very promising technology and I have faith the company will execute on it. With their patent secured they are now free to aggressively license their technology. They are in 100 storefronts in Colorado and inked their first Cali deal (I believe in Oakland) earlier this year. I expected many more where that came from. Furthermore, they have fully stated their intention to uplist to OTCQX which imo is the greatest catalyst in the near term. Until that happens they will be shut out from many potential investors that don't touch the grey market. They are already listed in Canada however under NSHS which is a huge plus. I expect them to end the year with a close to 100mil mktcap assuming they uplist and announce at least one major license / royalty deal.

Seems like a promising stock to me. Anyone else have an opinion?

Shouldn't this stocks symbol be NSHSF?